ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 258625 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 258625; 2) Community: the network communities that were significantly associated with the response to NSC 258625; 3) Molecule: the relationships between components within communities and NSC 258625; 4) MDR: the compounds that were significantly associated with the NSC 258625.

NSC Compound Enrichment Correlation
NSC 227279 1,4-Naphthalenedione, 5,8-dihydroxy-2,3-bis(hydroxymethyl)- 0.0385613993886001 0.56930477
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0385613993886001 -0.3199928
NSC 339137 PHYSALOLACTONE 0.0385613993886001 0.29453154
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0385613993886001 -0.11603675
NSC 42972 Null 0.0385613993886001 0.71955679
NSC 55236 Null 0.0385613993886001 0.40777883
NSC 601518 Null 0.0385613993886001 0.57176598
NSC 624657 ANTINEOPLASTIC-624657 0.0385613993886001 0.40088416
NSC 642947 Methanone, [3-(dibromomethyl)-6-chloroquinolin-2-yl] phenyl- 0.0385613993886001 0.27007812
NSC 645571 Null 0.0385613993886001 0.30908852
Total:91  Current:63    [First] [Prev] [Next] [Last]